Differentiation, distribution and γδ T cell-driven regulation of IL-22-producing T cells in tuberculosis

PLoS Pathogens

Volumn 6, Issue 2, 2010, Pages

  Yao, Shuyu ^a   Huang, Dan ^a   Chen, Crystal Y ^a   Halliday, Lisa ^b   Zeng, Gucheng ^a   Wang, Richard C ^a   Chen, Zheng W ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 22; NEUTRALIZING ANTIBODY; SILVER; 4 HYDROXY 3 METHYL 2 BUTENYL DIPHOSPHATE; 4-HYDROXY-3-METHYL-2-BUTENYL DIPHOSPHATE; BACTERIAL ANTIGEN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; LYMPHOCYTE ANTIGEN RECEPTOR; ORGANOPHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LUNG GRANULOMA; LUNG LAVAGE; LUNG PARENCHYMA; LUNG TUBERCULOSIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOID TISSUE; MACACA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN FUNCTION; T LYMPHOCYTE; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS; PRIMATES;

ANIMALS; ANTIGENS, BACTERIAL; CELL DIFFERENTIATION; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MACACA; MICROSCOPY, CONFOCAL; MYCOBACTERIUM TUBERCULOSIS; PHOSPHORIC ACID ESTERS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 77649251539     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000789     Document Type: Article

References (37)

1. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, et al. (2008) Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29: 947-957.
2. Wolk K, Sabat R (2006) Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17: 367-380.
3. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, et al. (2007) Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659.
4. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
5. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271-2279.
6. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275-281.
7. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289.
8. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651.
9. Ma HL, Liang S, Li J, Napierata L, Brown T, et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118: 597-607.
10. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
11. North RJ, Jung YJ (2004) Immunity to tuberculosis. Annu Rev Immunol 22: 599-623.
12. Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93-129.
13. Lockhart E, Green AM, Flynn JL (2006) IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177: 4662-4669.
14. Qiu L, Huang D, Chen CY, Wang R, Shen L, et al. (2008) Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 198: 1514-1519.
15. Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, et al. (2008) Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180: 1962-1970.
16. Chen ZW (2005) Immune regulation of gammadelta T cell responses in mycobacterial infections. Clin Immunol 116: 202-207.
17. Sicard H, Ingoure S, Luciani B, Serraz C, Fournie JJ, et al. (2005) In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J Immunol 175: 5471-5480.
18. Ottones F, Dornand J, Naroeni A, Liautard JP, Favero J (2000) V gamma 9V delta 2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect. J Immunol 165: 7133-7139.
19. Poccia F, Agrati C, Martini F, Capobianchi MR, Wallace M, et al. (2005) Antiviral reactivities of gammadelta T cells. Microbes Infect 7: 518-528.
20. Poccia F, Battistini L, Cipriani B, Mancino G, Martini F, et al. (1999) Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J Infect Dis 180: 858-861.
21. Shen Y, Zhou D, Qiu L, Lai X, Simon M, et al. (2002) Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 295: 2255-2258.
22. Wang L, Kamath A, Das H, Li L, Bukowski JF (2001) Antibacterial effect of human V gamma 2V delta 2 T cells in vivo. J Clin Invest 108: 1349-1357.
23. Spencer CT, Abate G, Blazevic A, Hoft DF (2008) Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity. J Immunol 181: 4471-4484.
24. Hintz M, Reichenberg A, Altincicek B, Bahr U, Gschwind RM, et al. (2001) Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli. FEBS Lett 509: 317-322.
25. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, et al. (1995) Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375: 155-158.
26. Altincicek B, Moll J, Campos N, Foerster G, Beck E, et al. (2001) Cutting edge: human gamma delta T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J Immunol 166: 3655-3658.
27. Belmant C, Espinosa E, Poupot R, Peyrat MA, Guiraud M, et al. (1999) 3-Formyl-1-butyl pyrophosphate A novel mycobacterial metabolite-activating human gammadelta T cells. J Biol Chem 274: 32079-32084.
28. Wei H, Huang D, Lai X, Chen M, Zhong W, et al. (2008) Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. J Immunol 181: 4798-4806.
29. Ali Z, Shao L, Halliday L, Reichenberg A, Hintz M, et al. (2007) Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaques. J Immunol 179: 8287-8296.
30. Gong G, Shao L, Wang Y, Chen CY, Huang D, et al. (2009) Phosphoantigen-activated V{gamma}2V{delta}2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection. Blood 113: 837-845.
31. Huang D, Shen Y, Qiu L, Chen CY, Shen L, et al. (2008) Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection. Infect Immun 76: 426-436.
32. Chen CY, Huang D, Wang RC, Shen L, Zeng G, et al. (2009) A Critical Role for CD8 T cells in a Nonhuman Primate Model of Tuberculosis. PLoS Pathog 5: 1000392. doi:10.1371/journal.ppat.1000392.
33. Chen Y, Shao L, Ali Z, Cai J, Chen ZW (2008) NSOM/QD-based nanoscale immunofluorescence imaging of antigen-specific T-cell receptor responses during an in vivo clonal V{gamma}2V{delta}2 T-cell expansion. Blood 111: 4220-4232.
34. Sanchez FO, Rodriguez JI, Agudelo G, Garcia LF (1994) Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 62: 5673-5678.
35. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, et al. (1995) T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 63: 3231-3234.
36. Gong JH, Zhang M, Modlin RL, Linsley PS, Iyer D, et al. (1996) Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 64: 913-918.
37. Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467.